ICR scientists study cancer response to new class of drugs
The research could help determine drug responses through genetic testing
Read More
Tag: ICR London
ICR’s new study tracks disease progression in children with rare type of cancer
Researchers assessed whether measuring DNA shed by cancer cells into the bloodstream could track tumour progression
Read More
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
